SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027545
Filing Date
2021-05-13
Accepted
2021-05-13 16:10:56
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-10q_20210331.htm   iXBRL 10-Q 1712112
2 EX-31.1 bolt-ex311_38.htm EX-31.1 14606
3 EX-31.2 bolt-ex312_37.htm EX-31.2 14573
4 EX-32.1 bolt-ex321_35.htm EX-32.1 5070
5 EX-32.2 bolt-ex322_36.htm EX-32.2 5789
  Complete submission text file 0001564590-21-027545.txt   6342944

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bolt-20210331.xsd EX-101.SCH 53382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bolt-20210331_cal.xml EX-101.CAL 50135
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bolt-20210331_def.xml EX-101.DEF 144943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bolt-20210331_lab.xml EX-101.LAB 372150
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bolt-20210331_pre.xml EX-101.PRE 282506
11 EXTRACTED XBRL INSTANCE DOCUMENT bolt-10q_20210331_htm.xml XML 1109405
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 21919722
SIC: 2834 Pharmaceutical Preparations